In Vitro Binding and Partitioning of Irinotecan (CPT-11) and its Metabolite, SN-38, in Human Blood Olivier CombesJérôme BarréSaïk Urien OriginalPaper Pages: 1 - 5
Development of Target-Based Antineoplastic Agents Walter M. StadlerMark J. Ratain OriginalPaper Pages: 7 - 16
Advanced Non-Small Cell Lung Carcinoma: The Emerging Role of Docetaxel Corey J. Langer OriginalPaper Pages: 17 - 28
Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) Christian ManegoldPetr ZatloukalJohannes Blatter OriginalPaper Pages: 29 - 42
Current Approaches and Future Strategies for Pancreatic Carcinoma Robert A. WolffPaul ChiaoJames L. Abbruzzese OriginalPaper Pages: 43 - 56
A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer G. SchwartsmannH. SchunemannD.R. Mans OriginalPaper Pages: 83 - 91